GTBP GT BIOPHARMA INC Management Changes 8-K Filing 2025 - Appointments On April 29, 2025, GT Biopharma, Inc. appointed Michael Breen as its Chief Executive Officer for a two-year term, having previously served as Interim CEO since March 2, 2022.Get access to all SEC 8-K filings of the GT BIOPHARMA INC